VIVO Starts Extraction Operations in Napanee, Ontario

VIVO Cannabis (TSXV:VIVO,OTCQX:VVCIF) announced Tuesday (July 30) that the company’s subsidiary, ABcann Medicinals, has received approval from Health Canada to start extraction operations using its CO₂ extraction system.

As quoted in the press release:

“We are extremely excited to commence CO2 extraction operations at our Napanee facility,” said Gary McMullen, Vice-President, Napanee Operations. “We are now capable of producing cannabis oils and concentrates to our exact specifications, which is important for meeting our stated production targets to support the sales of our premium brands and customized offerings, including Canna Farms™, Fireside™, Lumina™ and Beacon Medical as well as providing extraction services to third parties.”

Upon receipt of EU-GMP certification for its Napanee facility, the Company is expected to be able to ship extracted cannabis products to Europe and other countries for scientific and medical purposes, subject to receipt of all necessary import and export permits, in addition to selling domestically.

“The launch of our extraction operation in Napanee reinforces our commitment to innovation as we pivot our Napanee facility into a high caliber and efficient producer of value-added cannabis-based products,” said Barry Fishman, CEO of VIVO.

Click here to read the full press release.